Does Covid follow seasonal patterns? Here’s what WHO has to say

By: |
August 10, 2020 7:34 PM

This virus has demonstrated no seasonal pattern as such, said Dr Michael Ryan at a press briefing on Monday.

Ryan said the U.N. health agency continues to advise countries even where COVID-19 appears to be under control, such as those in Europe, to maintain measures to slow virus spread.

The emergencies chief for the World Health Organization said that COVID-19 doesn’t seem to follow the seasonal patterns that some viruses exhibit, making it harder to control. Unlike other respiratory viruses like influenza that spread mainly in the winter, the coronavirus pandemic is accelerating in the summer. That’s despite earlier predictions from some scientists and politicians it would fade in the heat.

This virus has demonstrated no seasonal pattern as such, said Dr Michael Ryan at a press briefing on Monday. What it has clearly demonstrated is that if you take the pressure off the virus, the virus bounces back, he said.  Ryan said the U.N. health agency continues to advise countries even where COVID-19 appears to be under control, such as those in Europe, to maintain measures to slow virus spread.

He called for countries where transmission remains intense, such as Brazil, to adopt measures so that communities have the necessary support they need to implement strategies like social distancing, wearing masks, and self-isolating if they have symptoms.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1How many health workers were infected or died during COVID duty? No data maintained by Central govt
2Bars in Andhra Pradesh to be re-opened from September 19
3Coronavirus vaccine: EU seals second coronavirus vaccine deal